Encompass Health Corporation (EHC)
- Previous Close
80.33 - Open
80.77 - Bid 82.06 x 1000
- Ask 82.11 x 800
- Day's Range
80.49 - 82.42 - 52 Week Range
57.55 - 83.73 - Volume
338,559 - Avg. Volume
680,398 - Market Cap (intraday)
8.215B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
22.85 - EPS (TTM)
3.59 - Earnings Date Apr 24, 2024
- Forward Dividend & Yield 0.60 (0.75%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
89.20
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
www.encompasshealth.com22,356
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHC
Performance Overview: EHC
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHC
Valuation Measures
Market Cap
8.04B
Enterprise Value
10.91B
Trailing P/E
22.38
Forward P/E
20.41
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.69
Price/Book (mrq)
4.88
Enterprise Value/Revenue
2.27
Enterprise Value/EBITDA
10.65
Financial Highlights
Profitability and Income Statement
Profit Margin
7.33%
Return on Assets (ttm)
7.79%
Return on Equity (ttm)
22.84%
Revenue (ttm)
4.8B
Net Income Avi to Common (ttm)
361.6M
Diluted EPS (ttm)
3.59
Balance Sheet and Cash Flow
Total Cash (mrq)
69.1M
Total Debt/Equity (mrq)
127.67%
Levered Free Cash Flow (ttm)
123.69M
Research Analysis: EHC
Company Insights: EHC
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: EHC
EHC: Lowering target price to $84.00
ENCOMPASS HEALTH CORP has an Investment Rating of HOLD; a target price of $84.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetEHC: What does Argus have to say about EHC?
ENCOMPASS HEALTH CORP has an Investment Rating of HOLD; a target price of $86.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetEHC: Raising target price to $86.00
ENCOMPASS HEALTH CORP has an Investment Rating of HOLD; a target price of $86.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetEHC: What does Argus have to say about EHC?
ENCOMPASS HEALTH CORP has an Investment Rating of HOLD; a target price of $81.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target